Today: 21 June 2026

Branson’s Bold Move: Virgin Trains Poised to End Eurostar’s 30-Year Channel Tunnel Monopoly

Branson’s Bold Move: Virgin Trains Poised to End Eurostar’s 30-Year Channel Tunnel Monopoly

The UK rail regulator has approved Virgin Trains’ use of the Temple Mills depot in London, ending Eurostar’s exclusive hold on Channel Tunnel passenger services. Virgin plans to launch international trains by 2030, unlocking £700 million of private investment and creating 400 jobs. The government is also pushing to reopen Kent’s Ashford and Ebbsfleet stations for new cross-Channel routes.
30 October 2025
·
Anthropic’s Private Shares Soar to $185 Amid AI Frenzy – $183B Valuation, Major Deals & $1.5B Lawsuit

Anthropic’s Private Shares Soar to $185 Amid AI Frenzy – $183B Valuation, Major Deals & $1.5B Lawsuit

Anthropic’s private share price surged 1,555% in a week to $185.90 on Oct. 29, 2025, implying a $241 billion valuation, per Forge Global. The company raised $13 billion in September at a $183 billion valuation and reported run-rate revenue rising from $1 billion to $5 billion by August. A U.S. judge preliminarily approved a $1.5 billion copyright settlement. LSEG and Alphabet shares rose on Anthropic partnership news.
30 October 2025
····
Nasdaq Frenzy: Tech Titans’ AI-Fueled Surge Hits Records Ahead of Fed Cut & Earnings Bonanza

Stocks in Limbo: Dow Futures Dip While Nasdaq, S&P Tick Up as Powell Cools Rally, Trump-Xi Deal Sparks Mixed Reaction

Dow futures fell about 0.15% early Oct 30, while S&P 500 and Nasdaq futures edged higher as markets reacted to the Fed’s 25bp rate cut and Powell’s warning that further cuts aren’t assured. The Nasdaq closed at a record on Oct 29, but Microsoft and Meta dropped after hours on earnings news. Trump announced a one-year “mini-deal” with China, suspending some tariffs. Oil rose on U.S. inventory draws; gold slipped from highs.
30 October 2025
·······
Michigan’s Green Energy Boom: Utilities Hit 50% Renewables Target as Solar Grants Surge

DTE Energy Stock Poised for Breakout? Investors Eye AI Boom and $10B Grid Plan

DTE Energy closed at $138.9 on Oct. 29, near its 52-week high, and will report Q3 earnings before market open Oct. 30. The company spent $1.8 billion on grid and renewable projects in H1 2025 and broke ground on a major Detroit solar field Oct. 27. Brenda Craig was named Chief Communications Officer, effective Oct. 30. Wall Street rates DTE a “Moderate Buy,” with average price targets in the mid-$140s.
30 October 2025
···
Crypto Frenzy: Bitcoin Wavers at $120K, Altcoins Roar, Regulators Act, and NFTs Rebound (July 22–23, 2025)

Bitcoin’s October 2025 Rollercoaster: Hits $126K, 17% Crash, and Fed-Fueled Comeback

Bitcoin plunged 15–17% to around $104,800 on Oct. 10 after hitting a record high near $126,223, triggering over $19 billion in crypto liquidations. By Oct. 29–30, it recovered to $110,000–113,000. Crypto ETFs saw record inflows, with U.S. Bitcoin ETFs now managing over $100 billion. The Federal Reserve cut rates by 25 bps on Oct. 29; Bitcoin dipped 3% on the news.
30 October 2025
··
Alien Probe or Cosmic Relic? Interstellar Comet 3I/ATLAS Baffles Scientists (updated 27.10.2025)

Mysterious Interstellar Comet 3I/ATLAS Nears Sun – 10-Billion-Year Visitor Sparks Alien Theories and Scientific Awe

Comet 3I/ATLAS, discovered July 1, 2025 by the ATLAS survey in Chile, is the third known interstellar object to enter our solar system. It reached perihelion on October 29, passing inside Mars’ orbit at 1.36 AU from the Sun, and will approach Earth to within 1.8 AU in December. The comet is traveling at 58 km/s and may be up to 5.6 km wide, making it the largest interstellar visitor yet observed.
29 October 2025
·
Microsoft’s $135B AI Bet Pays Off – Stock Soars as OpenAI Unveils $500B Restructure

Microsoft’s $135B AI Bet Pays Off – Stock Soars as OpenAI Unveils $500B Restructure

OpenAI finalized a major restructuring on Oct. 28, 2025, splitting into a nonprofit foundation and a for-profit Public Benefit Corp controlled by the nonprofit. Microsoft now owns 27% of the for-profit arm, valued at about $135 billion, and OpenAI committed to buy $250 billion in Azure services. OpenAI plans to spend $1.4 trillion on AI infrastructure in the coming years. Microsoft shares rose 4% intraday, hitting a record high.
29 October 2025
···
Nothing Phone 3a Lite Launch: 5,000mAh Battery, 50MP Triple Camera & Glyph LED at €249

Nothing Phone 3a Lite Launch: 5,000mAh Battery, 50MP Triple Camera & Glyph LED at €249

Nothing will launch the Phone (3a) Lite in Europe and the UK on October 29, starting at €249 for 8GB RAM and 128GB storage. The device features a transparent back with a single “Glyph” LED, a 6.77-inch FullHD+ AMOLED display, MediaTek Dimensity 7300 Pro chipset, and a 5,000mAh battery. It runs Android 15 with Nothing OS 3.5 and promises three years of OS updates. No US release is planned.
29 October 2025
··
Starbucks (SBUX) Brewing Gains? CEO’s Shake-Up & $5B China Deal Fuel Stock Rally

Starbucks Rebound? Q4 Sales Jump for First Time in 2 Years, Sending Stock Soaring

Starbucks reported a 1% rise in global same-store sales for Q4, its first increase in seven quarters, driven by international growth. Net revenue reached $9.6 billion, beating expectations, but profits fell sharply after a $1 billion restructuring charge and 627 store closures. Adjusted EPS came in at $0.52, missing forecasts. Shares rose about 2% after hours; the company suspended guidance pending a January update.
29 October 2025
·
Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

Constellation Software shares closed at C$3,453.88 on Oct. 29, down 8% for the day and nearly 30% below their 52-week high. Founder Mark Leonard resigned as president in late September for health reasons; Mark Miller was promoted. Q2 revenue rose 15% to US$2.84 billion, but GAAP net income dropped 68% on one-time items. Analysts remain bullish, with an average target of C$5,450.
29 October 2025
·
ServiceNow (NOW) Stock Soars on AI-Driven Earnings and 5-for-1 Stock Split

ServiceNow (NOW) Stock Soars on AI-Driven Earnings and 5-for-1 Stock Split

ServiceNow shares closed at $911.70 on Oct. 29, down 2.8%, but jumped about 4% in after-hours trading after strong Q3 results and a five-for-one stock split announcement. Subscription revenue rose 21.5% to $3.30 billion, beating forecasts. The company raised its full-year sales outlook. Analysts maintain a “Strong Buy” rating, with average targets near $1,117.
29 October 2025
···
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle shares closed at $40.40 on Oct. 29, down 31% from early 2025. The company reported Q3 adjusted EPS of $0.29 on $3.00 billion revenue, missing sales estimates and posting just 0.3% same-store growth. Management cut its 2025 outlook for the third time, now expecting same-store sales to decline. The stock fell 1–2% after hours following the update.
29 October 2025
··
MercadoLibre Stock Slides Amid Fintech Boom – Analysts Predict Big 2025 Comeback

MercadoLibre Stock Dips After Q3 Earnings Miss – Can Brazil Deal Ignite a Rally?

MercadoLibre closed at $2,290 on Oct. 28, up 20% year-to-date, with a market cap near $116 billion. Q3 revenue rose 39% to $7.41 billion, beating estimates, but net income of $421 million missed forecasts. The company announced a deal to sell Casas Bahia appliances and entered Brazil’s online pharmacy market. Shares dipped 1.6% after earnings; most analysts remain bullish with a $2,800 target.
29 October 2025
···
Symbotic Stock Skyrockets on AI Robotics Boom – Is SYM’s 200% Rally Just the Start?

Symbotic Stock Skyrockets on AI Robotics Boom – Is SYM’s 200% Rally Just the Start?

Symbotic Inc. shares surged 4% to around $71–$72 on October 29, nearing their record high. The stock is up over 170% in 2025, driven by demand for AI and robotics, but analysts remain divided, with a consensus “Hold” and price targets far below current levels. Fiscal Q3 revenue rose 26% to $592 million, beating forecasts, while the company reported a $22.4 billion backlog. Symbotic acquired Walmart’s robotics arm and launched new automation tech this year.
29 October 2025
···
ProPetro (PUMP) Soars on Data Center Power Deal and Q3 Earnings Beat – What’s Driving the Rally?

ProPetro (PUMP) Soars on Data Center Power Deal and Q3 Earnings Beat – What’s Driving the Rally?

ProPetro shares surged nearly 14% after its PROPWR unit secured a long-term contract to supply 60 megawatts to a major data center. Q3 revenue reached about $294 million, down 18.6% year-over-year but beating estimates by 14%. The company narrowed its quarterly loss to $2 million and reported $25 million in free cash flow from fracking. PROPWR’s total contracted capacity now exceeds 150 MW.
29 October 2025
····
Purple Biotech (PPBT) Stock Skyrockets ~100% on Breakthrough News – What’s Driving the Surge?

Purple Biotech (PPBT) Stock Skyrockets ~100% on Breakthrough News – What’s Driving the Surge?

Purple Biotech (NASDAQ: PPBT) shares surged 82% to $1.06 on October 29 after announcing a manufacturing breakthrough for its tri-specific antibody IM1240. The company, recently out of Nasdaq compliance for trading under $1, plans a 2026 IND filing. Analysts remain bullish despite ongoing losses and volatility. Purple raised $6 million in September, with a shareholder meeting set for December 15.
29 October 2025
·
Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last?

Ernexa Therapeutics (ERNA) Skyrockets on Cancer Therapy Deal – Will Rally Last?

Ernexa Therapeutics shares jumped nearly 50% to $1.80 intraday on October 29, 2025, after announcing a manufacturing partnership with Cellipont Bioservices to advance its ovarian cancer cell therapy, ERNA-101, toward clinical trials. Trading volume surged. Despite the rally, ERNA stock remains down about 58% in 2025 and 89% year-on-year after previous setbacks and a reverse stock split.
29 October 2025
··
1 … 1,847 1,848 1,849 1,850 1,851 … 2,091

Stock Market Today

  • Six Fiserv Insiders Buy $1.72M in Shares Amid Leadership Shakeup
    June 21, 2026, 5:29 PM EDT. Six Fiserv (NASDAQ: FISV) executives and board members purchased 34,781 shares for about $1.72 million at an average price of $49.55, ahead of the Juneteenth market holiday. Despite these insider buys, shares dropped 3.4% to close at $47.86 on Thursday following CEO Mike Lyons' sudden departure, which raised doubts about the company's recovery. Top buyers include CFO Paul Todd and legal head Adam Rosman. Fiserv reaffirmed its 2026 outlook targeting 1%-3% organic revenue growth and $8.00-$8.30 adjusted earnings per share (EPS), implying a valuation of about 5.8-6.0 times expected EPS. Investors remain cautious amid leadership changes, with recent insider purchases not offsetting broader selling pressure.

Latest articles

Six Fiserv Insiders Bought $1.72M of NASDAQ: FISV Ahead of Holiday

Six Fiserv Insiders Bought $1.72M of NASDAQ: FISV Ahead of Holiday

21 June 2026
Six Fiserv insiders bought 34,781 shares for $1.72 million after CEO Mike Lyons’ abrupt exit, but FISV closed at $47.86—down 3.4% from their $49.55 average price and 10.9% since the leadership change—leaving the group with a $58,783 paper loss as the stock trades at just 5.8–6.0 times reaffirmed 2026 adjusted EPS guidance, with investors awaiting proof of a turnaround.
CoreWeave edges higher before Nasdaq-100 debut, week looks ahead to debt moves

CoreWeave stock moves up as it eyes Nasdaq-100 after 17% weekly gain

21 June 2026
CoreWeave will join the Nasdaq-100 before Monday’s open, triggering index fund buying tracked by over $800 billion in assets; shares closed Thursday at $117.95, up 17.3% in five days, as investors weigh AI infrastructure demand against heavy capital spending and a widened Q1 net loss of $740 million.
FDA Readout Looms for ACHV, UNCY; Market Sees Split Odds

FDA Readout Looms for ACHV, UNCY; Market Sees Split Odds

21 June 2026
Achieve Life Sciences plunged 9.51% to $4.85 as its June 20 FDA deadline for cytisinicline passed with a manufacturing-related rejection expected; Unicycive Therapeutics dropped 2.84% to $6.85 ahead of a June 29 FDA decision, with both stocks’ applications limited by third-party manufacturing issues, not efficacy, and liquidity representing 39.7% and 31.2% of implied equity values, respectively.
Go toTop